Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × avapritinib × Sarcoma × Clear all

Status

Completed 5 Recruiting 1 No longer available 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Glioma 1 Gastrointestinal Stromal Tumors 1

Interventions

Trabectedin 2 tazemetostat 1 regorafenib 1 omburtamab I-131 1 nirogacestat 1 ganitumab 1 fludarabine phosphate 1 avapritinib 1 Whole-Body Irradiation 1 Tacrolimus 1 TH 302 1 Mycophenolic Acid 1 Everolimus 1 DOXO-EMCH 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04714086 2024-10-24

Expanded Access Program for Avapritinib

Blueprint Medicines Corporation

No longer available

CNSGastrointestinalSarcoma

Glioma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡